跳至主要内容
临床试验/NCT02864212
NCT02864212Unknown不适用

Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage

Coordinación de Investigación en Salud, Mexico1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
Glucose

研究概览

简要总结

The aim of this observational study is to create a data base to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.

详细描述

The aim of this observational study is to create a database to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.

The observed drugs in this study are fast acting insulin, propofol and sodium nitroprusside.

The effect of insulin will be measured by a continuous glucose monitor, the effect of propofol by a bispectral index monitor and the the effect of sodium nitroprusside by a invasive blood pressure monitor.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status I, II, II

排除标准

  • Impossibility to measure depth of anesthesia or invasive blood pressure. Impossibility of using glucose monitor.

结局指标

主要结局

Glucose

时间窗: Every 5 minutes during 3 days.

The glucose will be measured by a continuous glucose monitor. For the group of patients for diabetes. Note: This protocol has three primary outputs because its objective is to create a database of each output to analyze the response to the associated drug (insulin, propofol and sodium nitroprusside.

Bispectral Index

时间窗: Every second during surgery

Depth of anesthesia will be measured by a Bispectral Index monitor.

Invasive blood pressure

时间窗: Every 5 minutes during surgery

次要结局

未报告次要终点

研究者

发起方
Coordinación de Investigación en Salud, Mexico
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验